Lin Shuan-Pei, Huang Shu-Yi, Tu Mei-Eng, Wu Yu-Hung, Lin Cheng-Yueh, Lin Hsiang-Yu, Lee-Chen Guey-Jen
Division of Genetics and Metabolism, Departments of Pediatrics and Medical Research, Mackay Memorial Hospital, Taipei, Taiwan.
Arch Dermatol Res. 2007 Jun;299(3):145-50. doi: 10.1007/s00403-007-0751-z. Epub 2007 Apr 6.
Netherton syndrome (NS) is a severe autosomal recessive skin disorder characterized by congenital ichthyosiform erythroderma, hair shaft abnormalities, and atopic diathesis. Recently, pathogenic mutations were identified in serine protease inhibitor Kazal-type 5 (SPINK5), the gene that encodes lympho-epithelial Kazal-type related inhibitor (LEKTI), a type of serine protease inhibitor involved in the regulation of skin barrier formation and immunity. In the present report, we describe the mutation analysis of two Taiwanese patients with NS. Patient 1 has heterozygous mutations; the maternal allele has novel T808I (C-T transition in codon 808) and the paternal allele has recurrent R790X (C-T transition in codon 790). Patient 2 is homozygous for a novel polymorphism R267Q (G-A transition in codon 267). The change was not detected in the patient's father. Haplotype analysis revealed that the patient was homozygous for the 5 single nucleotide polymorphisms in the genomic sequence of SPINK5 as well as the flanking (GT)(17) and D5S413, in addition to the discrepancy of R267Q. Nevertheless real-time quantitative PCR analysis revealed no microdeletion in the genomic sequence of SPINK5. Thus uniparental disomy of maternal SPINK5 allele was indicated.
Netherton综合征(NS)是一种严重的常染色体隐性遗传性皮肤病,其特征为先天性鱼鳞病样红皮病、毛干异常和特应性素质。最近,在丝氨酸蛋白酶抑制剂Kazal型5(SPINK5)基因中发现了致病突变,该基因编码淋巴细胞上皮Kazal型相关抑制剂(LEKTI),这是一种参与皮肤屏障形成和免疫调节的丝氨酸蛋白酶抑制剂。在本报告中,我们描述了两名台湾NS患者的突变分析。患者1有杂合突变;母本等位基因有新的T808I(密码子808处的C-T转换),父本等位基因有复发性R790X(密码子790处的C-T转换)。患者2是新多态性R267Q(密码子267处的G-A转换)的纯合子。在患者父亲中未检测到该变化。单倍型分析显示,除了R267Q的差异外,患者在SPINK5基因组序列以及侧翼(GT)(17)和D5S413中的5个单核苷酸多态性上是纯合的。然而,实时定量PCR分析显示SPINK5基因组序列中没有微缺失。因此提示存在母本SPINK5等位基因的单亲二体。